By: Jim Van Meerten
Jim Van Meerten Barchart NeoGenomics (NEO) is a leading cancer genetics diagnostics lab. Its stock recently hit a new 2-year high.
Jim Van Meerten is a Contributor at various financial and agricultural platforms. He specializes in finance, personal finance, and agriculture, with a focus on commodities, futures, and the intricacies of mining operations, oil, and gas. Jim's insights and analyses have been featured in prominent publications such as Seeking Alpha, Yahoo Finance, and Nasdaq.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Jim's coverage primarily focuses on data and analytics in the context of technology, stocks, investing, software, and artificial intelligence. He seems to be most interested in analyzing charts and providing investment insights based on data.
If you are reaching out to Jim Van Meerten, consider offering him access to exclusive data or unique analysis related to technology companies or stock performance. Additionally, if you have expertise in investment analysis with a strong basis in data interpretation within the tech industry, your input may be well-received by Jim.
This information evolves through artificial intelligence and human feedback. Improve this profile .